Preview

Rational Pharmacotherapy in Cardiology

Advanced search

EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE

https://doi.org/10.20996/1819-6446-2010-6-2-212-215

Full Text:

Abstract

Data about efficacy and safety of acetylsalicylic acid usage as antiplatelet drug and for cancer prevention are presented.

About the Authors

V. N. Drozdov
Central Research Institute of Gastroenterology
Russian Federation
Entuziastov shosse 86, Moscow, 111123


V. A. Kim
Central Research Institute of Gastroenterology
Russian Federation
Entuziastov shosse 86, Moscow, 111123


References

1. Кропачева Е.С. Аспирин как безопасная основа антитромботической терапии. Атмосфера. Новости кардиологии 2008;(1):8-12.

2. Карпов Ю.А. Ацетилсалициловая кислота — ключевая позиция в первичной и вторичной профилактике сердечно-сосудистых заболеваний и их осложнений. РМЖ 2008;16(11):1554-8.

3. Cohen L.S. Clinical pharmacology of acetylsalicylic acid. Semin Thromb Hemost 1976;2(3):146-75.

4. International Stroke Trial Collaborative Group. The International Stroke Trial (1ST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 1997;349(9065):1569-81.

5. CAST (ChineseAcute Stroke Trial) Collaborative Group. CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 1997;349(9066):1641-9.

6. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration. BMJ 2002;324(7329):71-86.

7. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;2(8607):349-60.

8. Mangano D.T., Miao Y., Vuylsteke A. et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007;297(5):471-9.

9. Juul-Möller S., Edvardsson N.,Jahnmatz B. et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992;340(8833):1421-5.

10. Sandler R.S., Halabi S., Baron J.A. et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N EnglJ Med 2003;348(10):883- 90.

11. Baron J.A., Cole B.F., Sandler R.S. et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348(10):891-9.

12. Flossmann E., Rothwell P.M. British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007;369(9573):1603-13.

13. Chan A.T., Giovannucci E.L., Meyerhardt J.A. et al. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 2008;134(1):21-8.

14. SwedishAspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascularischaemic events. The SALT Collaborative Group. Lancet 1991;338(8779):1345- 9.

15. Насонов Е.Л., Лазебник Л.Б., Мареев В.Ю. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.; 2006.

16. Куликов А.Ю., Крысанова И.С. Фармакоэкономический анализ антиагрегантной терапии у пациентов с ИБС и высоким риском гастропатии. Клиническая фармакология и терапия 2007;16(1):62-5.

17. Вёрткин А.Л., Аристархова О.Ю., Адонина Е.В. и др. Безопасность и фармакоэкономическая эффективность применения различных препаратов ацетилсалициловой кислоты у пациентов с ИБС. РМЖ 2009;17(8):570-6.

18. Баркаган З.С., Момот А.П., Котовщикова Е.Ф., Шилова А.Н. Выбор препаратов и мониторинг эффективности антитромботических средств. Материалы научно-практической конференции «Острый коронарный синдром: проблемы патогенеза, профилактики, диагностики, классификации, терапии» 22-23 марта 2001. Томск; 2001. С.192-194.


For citation:


Drozdov V.N., Kim V.A. EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE. Rational Pharmacotherapy in Cardiology. 2010;6(2):212-215. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-2-212-215

Views: 457


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)